|
SYDNEY, June 5, 2026 /PRNewswire/ -- Trip.com, the global travel service provider, has officially launched its End of Financial Year (EOFY) Mega Sale, kicking off the winter travel season in style. From the week commencing 9 June 2026, Aussie travellers can access weekly rolling discounts, flash sales, and coupon drops designed to turn dream holidays into an affordable reality.
The EOFY Mega Sale is a chance to save big across flights, hotels, and travel essentials—with four big weekly drops starting from 9 June.
EOFY Mega Sale Calendar:
- Week 1 (9 June) — Travel Essentials Launch: Up to 50% off coupons for attractions and eSIMs, a free eSIM coupon (valued up to $2), 30% off car hire coupon, plus Buy 1 Get 1 Free offers on selected attractions
- Week 2 (16 June) — Hotel Mega Deals: Up to 70% off hotel coupons in addition to flash sales on accommodation from $9 per night
- Week 3 (23 June) — Flight Frenzy:
- $29 domestic flights between Sydney, Melbourne, Brisbane, Gold Coast and Adelaide
- $109 flights from Perth to Bali
- $149 flights from Sydney, Melbourne, and Brisbane to Bali and Ho Chi Minh City
- Up to 50% off flight coupons
- Week 4 (30 June) — Last Chance Deals: Final opportunity to secure the month's best travel bargains before the financial year closes.
Even Bigger Savings – Partner Airlines & Airports
Alongside the EOFY Mega Sale, Trip.com has teamed up with leading airlines and airports to deliver significant direct savings for Australians travelling overseas.
- This Is China: From today to 27 July, snag up to $100 off on flights from Sydney to China, valid across premium carriers including China Southern, China Eastern, Air China, and more. Flash sales are also available for flights from Sydney to Shanghai at $189 on 9 June and 7 July, and the same price also applies for flights from Sydney to Beijing on 23 June and 21 July.
- Brisbane Airport – Take Off To Asia: Queenslanders can score $50 off flights heading into Asia's popular hubs from today until 14 June.
- Fly with Batik Air: Discover Southeast Asia with up to $100 off flights from Sydney to destinations across Indonesia and Malaysia.
- Premium Global Airline Savings:Enjoy an instant $100 off for bookings with Malaysia Airlines with more airline partner discounts to be announced in due course.
Don't Miss Out – Get Ready Now
Download the Trip.com app now to grab these limited-time offers.
Terms and Conditions apply. All promotional offers are available on a first-come, first-served basis within the specified period and while stocks last. Please note that all deals are in AEST time.
For more information, please visit https://au.trip.com/.
About Trip.com
Trip.com is an international one-stop travel service provider, available in 27 languages across 48 countries and regions in 44 local currencies. Offering an extensive hotel and flight network of more than 1.7 million hotels and flights from over 680 airlines, along with over 350,000 in-destination activities, Trip.com covers 3,500 airports in 220 countries and regions. Trip.com's world-class 24/7 multilingual customer service helps to 'create the best travel experience' for its millions of customers worldwide. To book your next trip, visit Trip.com.
SYDNEY, June 5, 2026 /PRNewswire/ -- Trip.com, the global travel service provider, has officially launched its End of Financial Year (EOFY) Mega Sale, kicking off the winter travel season in style. From the week commencing 9 June 2026, Aussie travellers can access weekly rolling discounts, flash sales, and coupon drops designed to turn dream holidays into an affordable reality.
The EOFY Mega Sale is a chance to save big across flights, hotels, and travel essentials—with four big weekly drops starting from 9 June.
EOFY Mega Sale Calendar:
- Week 1 (9 June) — Travel Essentials Launch: Up to 50% off coupons for attractions and eSIMs, a free eSIM coupon (valued up to $2), 30% off car hire coupon, plus Buy 1 Get 1 Free offers on selected attractions
- Week 2 (16 June) — Hotel Mega Deals: Up to 70% off hotel coupons in addition to flash sales on accommodation from $9 per night
- Week 3 (23 June) — Flight Frenzy:
- $29 domestic flights between Sydney, Melbourne, Brisbane, Gold Coast and Adelaide
- $109 flights from Perth to Bali
- $149 flights from Sydney, Melbourne, and Brisbane to Bali and Ho Chi Minh City
- Up to 50% off flight coupons
- Week 4 (30 June) — Last Chance Deals: Final opportunity to secure the month's best travel bargains before the financial year closes.
Even Bigger Savings – Partner Airlines & Airports
Alongside the EOFY Mega Sale, Trip.com has teamed up with leading airlines and airports to deliver significant direct savings for Australians travelling overseas.
- This Is China: From today to 27 July, snag up to $100 off on flights from Sydney to China, valid across premium carriers including China Southern, China Eastern, Air China, and more. Flash sales are also available for flights from Sydney to Shanghai at $189 on 9 June and 7 July, and the same price also applies for flights from Sydney to Beijing on 23 June and 21 July.
- Brisbane Airport – Take Off To Asia: Queenslanders can score $50 off flights heading into Asia's popular hubs from today until 14 June.
- Fly with Batik Air: Discover Southeast Asia with up to $100 off flights from Sydney to destinations across Indonesia and Malaysia.
- Premium Global Airline Savings:Enjoy an instant $100 off for bookings with Malaysia Airlines with more airline partner discounts to be announced in due course.
Don't Miss Out – Get Ready Now
Download the Trip.com app now to grab these limited-time offers.
Terms and Conditions apply. All promotional offers are available on a first-come, first-served basis within the specified period and while stocks last. Please note that all deals are in AEST time.
For more information, please visit https://au.trip.com/.
About Trip.com
Trip.com is an international one-stop travel service provider, available in 27 languages across 48 countries and regions in 44 local currencies. Offering an extensive hotel and flight network of more than 1.7 million hotels and flights from over 680 airlines, along with over 350,000 in-destination activities, Trip.com covers 3,500 airports in 220 countries and regions. Trip.com's world-class 24/7 multilingual customer service helps to 'create the best travel experience' for its millions of customers worldwide. To book your next trip, visit Trip.com.
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
Trip.com Kicks Off Winter Travel Season with EOFY Mega Sale and Massive Flight Perks
Trip.com Kicks Off Winter Travel Season with EOFY Mega Sale and Massive Flight Perks
HONG KONG, June 5, 2026 /PRNewswire/ -- UniTrust Global Limited | UTGL announced a donation of HK$650,000 to Prime Healthcare Medical Services Limited in support of a clinical study on Enhanced External Counterpulsation (EECP). The donation reflects UTGL's long-term corporate vision of supporting local medical research, improving human health and well-being, and exploring cutting-edge anti-aging and regenerative technologies through corporate social responsibility.
The clinical study is titled "Efficacy and Dose-Response of Enhanced External Counterpulsation (EECP) on Blood Pressure in Pre-hypertension and Stage 1 Essential Hypertension: A Two-Phase, Randomized, Sham-Controlled Trial." It is expected to enrol 70 to 100 participants with pre-hypertension or Stage 1 essential hypertension and will adopt a two-phase, randomized, sham-controlled design to explore the potential impact and dose-response of EECP on blood pressure management. EECP is a non-invasive external therapy with established medical applications to improve blood flow and alleviate symptoms of chronic stable angina; its applicability and potential role in the study population require validation through rigorous clinical research.
The core narrative of this news release is that the clinical study targets pre-hypertension and Stage 1 essential hypertension; the research objective is to prudently explore potential improvements in hypertension; and improving hypertension is positioned as the starting point for obtaining important health signals. As a key indicator of cardiovascular health, blood pressure may provide clearer, more verifiable health signals at an early stage. Such signals can help society understand, in a more scientific manner, the connection between healthy longevity, chronic disease risk management, functional maintenance and technology innovation. UTGL emphasizes that this narrative is not a claim of EECP efficacy, but a responsible positioning of rigorous clinical research as a starting point for the broader vision of healthy longevity and regenerative technology.
Vision & Core Values
UniTrust Global Limited | UTGL believe that this study targeting pre-hypertension and Stage 1 essential hypertension is not only of meaningful reference value for the early management of chronic cardiovascular risk, but also closely aligns with UTGL's corporate vision of supporting the improvement of human health and well-being, and exploring cutting-edge anti-aging and regenerative technologies. Improving hypertension is the beginning of obtaining health signals; and health signals provide a more science-based direction for healthy longevity and anti-aging research."
The study is led by Dr. Lam Yat Yin. Dr. Lam is Chairman of Centre Medical Group, Director of Hong Kong Asia Heart Centre, a pioneer in structural heart disease intervention in the Asia-Pacific region, and co-developer of the LAmbre™ Left Atrial Appendage Occluder. UTGL believes that local clinical research led by specialists with deep experience in cardiovascular medicine and interventional therapy can help establish a more science-based discussion on healthy longevity and promote public understanding of preventive medicine, blood pressure health and life-science innovation.
Mr. Benjamin Leung, Chief Executive Officer of UTGL, and Mr. Derrick Wong, Managing Director of UTGL, represented the Company in supporting this research initiative. As a publicly licensed global private trust services specialist in Hong Kong, UTGL has long served high-net-worth clients, entrepreneurs and families, and understands that true long-term value lies not only in wealth and asset succession, but also in health, well-being and sustainable development for future generations. UTGL will continue to support research, education and community health initiatives with public value, guided by prudence, professionalism and a long-term perspective, while advancing evidence-based exploration from blood pressure health signals to a broader vision of healthy longevity.
About UniTrust Global Limited | UTGL
UniTrust Global Limited | UTGL is a publicly licensed global private trust services specialist in Hong Kong, operating under a government-bonded framework, dedicated to delivering premier asset protection and wealth administration services, while supporting community and human well-being through corporate social responsibility initiatives.
Media Contact
UniTrust Global Limited | UTGL
Website: www.utgl.net
Email: info@utgl.net
Medical Disclaimer
This news release is issued solely for corporate social responsibility and research-support information. It does not constitute medical advice, diagnosis, treatment recommendation, medical service promotion or any guarantee of therapeutic outcome. Whether EECP is suitable for any individual must be assessed by qualified healthcare professionals based on individual circumstances. The clinical study described herein is pending completion and validation, and readers should not interpret any study hypothesis, potential benefit, health signal, anti-aging, regenerative technology or healthy-longevity narrative as an established therapeutic effect, treatment commitment, blood pressure reduction guarantee, life-extension effect or rejuvenation effect.
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
UTGL Donates HK$650,000 to Advance Anti-Aging, Cardiovascular Health and Healthy Longevity Through Corporate Social Responsibility and Clinical Research
